Abstract |
The present experiment was performed to investigate the haemodynamic effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and alpha-methyl-5-hydroxytryptamine (alpha-methyl-5-HT) in the anaesthetised normotensive rat. DOI (1-300 micrograms/kg i.v.) increased mean arterial pressure (MAP), total peripheral resistance (TPR) and decreased cardiac output (CO) and heart rate (HR). DOI increased all vascular resistances investigated (hindquarters, mesenteric and renal). Alpha-methyl-5-HT (10-300 micrograms/kg i.v.) dose-dependently increased MAP, TPR, all regional vascular resistances and decreased CO and HR. The bradycardia induced by alpha-methyl-5-HT was suppressed by bivagotomy. Both DOI and alpha-methyl-5-HT were more effective on renal vascular bed than hindquarters and mesenteric vascular beds. The effects of DOI and alpha-methyl-5-HT were antagonised by spiperone (10 or 100 micrograms/kg i.v.) and LY 53857 (10 micrograms/kg i.v.). Intracerebroventricular administration of DOI (100 micrograms/kg) increased MAP, TPR, regional vascular resistances and did not change HR and CO. Pretreatment with xylamidine (10 micrograms/kg i.v.), a selective peripheral 5-HT2 receptor antagonist, blocked i.v. and i.c.v. effects of DOI. These results suggest that: 1) the increase in MAP induced by DOI and alpha-methyl-5-HT is due to an increase in TPR. All regional vascular beds and in particular the renal vascular bed participate in the increase of TPR. 2) Peripheral--and may be--central 5-HT2 receptors seem to be implicated in the control of regional vascular resistances. 3) Cardiac effects of alpha-methyl-5-HT are baroreflexly-mediated whereas those of DOI are--at least in part--centrally mediated.
|
Authors | K Chaouche-Teyara, B Fournier, M Safar, H Dabiré |
Journal | Clinical and experimental hypertension (New York, N.Y. : 1993)
(Clin Exp Hypertens)
Vol. 16
Issue 6
Pg. 779-98
(Nov 1994)
ISSN: 1064-1963 [Print] England |
PMID | 7858559
(Publication Type: Journal Article)
|
Chemical References |
- Amphetamines
- Ergolines
- Serotonin Antagonists
- Serotonin Receptor Agonists
- alpha-methylserotonin
- Serotonin
- Spiperone
- LY 53857
- 4-iodo-2,5-dimethoxyphenylisopropylamine
|
Topics |
- Amphetamines
(administration & dosage, pharmacology)
- Animals
- Dose-Response Relationship, Drug
- Ergolines
(pharmacology)
- Hemodynamics
(drug effects)
- Injections, Intravenous
- Injections, Intraventricular
- Male
- Rats
- Rats, Wistar
- Regional Blood Flow
(drug effects)
- Renal Circulation
(drug effects)
- Serotonin
(administration & dosage, analogs & derivatives, pharmacology)
- Serotonin Antagonists
(pharmacology)
- Serotonin Receptor Agonists
(administration & dosage, pharmacology)
- Spiperone
(pharmacology)
- Splanchnic Circulation
(drug effects)
|